CurrentCardio
Get Weekly

Topic · page 9 of 18

Valvular & structural heart disease

Aortic, mitral and tricuspid disease, TAVI/TEER, surgical valve therapy, PFO/LAA closure

Briefs 321–360 of 696 placed here, newest publication first

Briefs in Valvular & structural heart disease

Newest publication first

  1. JACC Cardiovasc Imaging

    Indexed Aortic Valve Calcium Volume by Computed Tomography Angiography in Patients With Aortic Stenosis: Results of an International Multicenter Cohort Study

    Cohort study

  2. Eur Heart J

    Outcomes of moderate mixed aortic valve stenosis and regurgitation

    Cohort study

  3. Europace

    Device-lead abnormalities and function after transcatheter tricuspid valve replacement

    Cohort study

  4. J Am Coll Cardiol

    Effect of Dapagliflozin on Quality of Life of Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation

    Secondary analysis

  5. JACC Cardiovasc Interv

    New-Onset Conductance Disturbances After Transcatheter Tricuspid Valve Replacement: A Mechanistic Assessment

    Cohort study

  6. Circulation

    Transcatheter Closure of Patent Foramen Ovale With a Novel Biodegradable Device: A Prospective, Multicenter, Randomized Controlled Clinical Trial

    Randomised controlled trial

  7. JACC Cardiovasc Interv

    CLASP IID Trial and Registry: 2-Year Outcomes of Transcatheter Repair for Degenerative Mitral Regurgitation

    Randomised controlled trial

  8. JACC Cardiovasc Interv

    Electrosurgical Leaflet Modification to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement in Failing Native and Bioprosthetic Valves

    Cohort study

  9. Heart Rhythm

    Alternative pacing strategies after transcatheter tricuspid valve interventions: Procedural challenges and lessons learned

    Cohort study

  10. JACC Cardiovasc Interv

    Dual vs Single Antiplatelet Therapy After Transcatheter Aortic Valve Replacement for Bioprosthetic Valve Failure

    Cohort study

  11. JACC Cardiovasc Imaging

    A Deep Learning Model to Identify Mitral Valve Prolapse From the Echocardiogram

    Diagnostic or prognostic study

  12. JACC Cardiovasc Interv

    1-Year Outcomes of Transfemoral Transcatheter Mitral Valve Replacement With the Eos System: The MISCEND Study

    Cohort study

  13. JACC Cardiovasc Interv

    Acceleration Time/Ejection Time Ratio Compared to Mean Gradient as a Predictor of Clinical Outcomes Post-TAVR

    Cohort study

  14. JACC Cardiovasc Interv

    Trends and Late Outcomes in Elderly Patients Undergoing Mitral Valve Interventions in the United States

    Cohort study

  15. J Am Coll Cardiol

    Moderate Secondary Mitral Regurgitation: Evolving Evidence and Management Strategies

    Research article

  16. Eur J Heart Fail

    Management of Aortic Stenosis and Chronic Heart Failure: A Clinical Consensus Statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC

    Guideline or statement

  17. Circulation

    Accelerometer-Measured Physical Activity After Mitral Valve Surgery: An Analysis of the UK Mini Mitral Randomized Controlled Trial

    Secondary analysis

  18. Eur Heart J

    Surgical left atrial appendage occlusion in valvular heart disease without atrial fibrillation: the OPINION trial

    Randomised controlled trial

  19. Circulation

    Clinical Presentation and Outcomes After Surgery for Mitral Regurgitation: Real-World Insights From the MITRACURE International Registry

    Cohort study

  20. Circulation

    Three-Year Follow-Up of the NOTION-2 Trial: TAVR Versus SAVR to Treat Younger Low-Risk Patients With Tricuspid or Bicuspid Aortic Stenosis

    Randomised controlled trial

  21. Eur J Heart Fail

    Left Ventricular Ejection Fraction and Benefit of Tricuspid Valve Interventions – Insights from the International TRIGISTRY

    Cohort study

  22. Circulation

    Peri-Interventional Anesthesia Strategies for Transcatheter Aortic Valve Implantation: A Multicenter, Randomized, Controlled, Noninferiority Trial

    Randomised controlled trial

  23. JACC Cardiovasc Interv

    30-Day and 1-Year Outcomes of Navitor Transcatheter Aortic Valve in Low- or Intermediate-Risk Patients

    Cohort study

  24. Eur Heart J

    Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial

    Secondary analysis

  25. JACC Cardiovasc Interv

    Refining Bleeding Risk Stratification After TAVR: Added Value of CT-ADP Beyond High Bleeding Risk Criteria

    Cohort study

  26. JACC Cardiovasc Interv

    Early U.S. Commercial Experience With a Novel Transcatheter Edge-to-Edge Repair System: Insights From Real-World Data

    Cohort study

  27. JACC Cardiovasc Interv

    Mid-Term Outcomes of Balloon-Expandable Aortic Valve-in-Valve Replacement in the United States

    Cohort study

  28. Circulation

    Transcatheter Aortic Valve Replacement With Balloon- Versus Self-Expandable Bioprostheses for the Treatment of Bicuspid Aortic Valve Stenosis

    Cohort study

  29. Circulation

    Long-Term Outcomes of Early Surgery Versus Conventional Treatment for Asymptomatic Severe Mitral Regurgitation: A Propensity Analysis

    Cohort study

  30. JACC Cardiovasc Interv

    Bicaval TricValve Implantation in Patients With Severe Tricuspid Regurgitation: 1-Year Outcomes From the TricBicaval Registry

    Cohort study

  31. JACC Cardiovasc Imaging

    Staging of Cardiac Adverse Remodeling in Moderate or Severe Aortic Regurgitation

    Cohort study

  32. Eur J Prev Cardiol

    Aortic stenosis risk and Life’s Crucial 9: the role of proteomics and inflammation

    Cohort study

  33. Eur Heart J

    Transcatheter edge-to-edge repair vs medical therapy in atrial functional mitral regurgitation: a propensity score-based comparison from the OCEAN-Mitral and REVEAL-AFMR registries

    Cohort study

  34. JACC Cardiovasc Interv

    Atrioventricular Conduction Disturbances in Patients Undergoing Transcatheter Tricuspid Valve Intervention: A Multidisciplinary Consensus

    Research article

  35. JACC Cardiovasc Interv

    Outcomes of Entrapped Right Ventricular Pacing or Defibrillator Leads Following Transcatheter Tricuspid Valve Replacement

    Cohort study

  36. JACC Cardiovasc Interv

    Redefining TAVR Valve Sizing: A Validated Multiplanar Approach for Both Bicuspid and Tricuspid Valves

    Cohort study

  37. JACC Cardiovasc Interv

    Same-Day Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement

    Cohort study

  38. JACC Cardiovasc Interv

    The Relevance of Right Ventricular Function and Dimension in Patients Undergoing Transcatheter Tricuspid Edge-to-Edge Repair

    Cohort study

  39. JACC Cardiovasc Interv

    Long-Term Outcomes of BAV-0 Patients Compared With BAV-1 and TAV Patients After TAVR

    Cohort study

  40. Eur J Heart Fail

    Heart Failure Hospitalizations and Clinical Outcomes in Patients Undergoing Tricuspid Transcatheter Edge-To-Edge Repair: Insights from EuroTR

    Cohort study

All 696 Briefs in ExploreShowing Briefs 321–360 of 696, newest first